Purchase Order 75N93023P01091

Award Date 9/1/23
Potential Completion Date 12/31/23
Potential Value $250K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $240,622 firm fixed price purchase order to Baylor College of Medicine. The contract calls for whole genome sequencing of 200 samples to support NIAID's research efforts. Specifically, the contractor will perform clinical whole genome sequencing, sample processing, and data analysis on samples provided by NIAID. The sequencing must meet CLIA and CAP...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $911,370 firm fixed price purchase order to Baylor College of Medicine. The contract calls for Baylor College of Medicine to provide whole genome sequencing services for 800 clinical samples with a six week turnaround time, and an additional 10 samples requiring sequencing and reporting within three weeks. The work will be performed in Houston, Texas and supports the NIH Clinical Center's...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Baylor College of Medicine, a private, non-profit university, for whole genome sequencing of 200 samples. The $240,621 contract has a completion date of August 15, 2021 and was awarded without a set-aside on July 20, 2021. The contract originated from a request for quotes solicitation for clinical whole genome sequencing...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $145,590 purchase order to Clinical Research Sequencing Platform, LLC for clinical genome sequencing services. The prime contractor, Clinical Research Sequencing Platform, LLC, is a division of The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard. The firm fixed price contract runs from August 30, 2023 through December 31, 2023 to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,850 purchase order to Novogene Corp Inc. to provide plant and animal eukaryotic mRNA sequencing services under Agricultural Marketing Service Blanket Purchase Agreement number 21833252. The firm fixed price contract runs from August 10, 2023 to October 31, 2023 and will be performed in Sacramento, California. No subcontractors or set aside designations...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $232,285.00 firm fixed price purchase order to Baylor College of Medicine, a private university and non-profit educational institution, for whole genome sequencing services. The order includes 200 standard and 5 rapid samples, with a completion date of October 31, 2022. This purchase order is not associated with a larger contract vehicle, and does not have a...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $249,996 firm fixed price purchase order to Gene By Gene, LTD for clinical grade whole genome sequencing services. The contract calls for Gene By Gene to deliver these sequencing services from its Houston, Texas facility between September 1, 2023 and December 31, 2023 to support NIAID's research efforts in the areas of allergy and infectious disease. No major subcontractors or set aside designations were identified. This purchase order will enable NIAID scientists to utilize advanced genomic technologies in furthering their mission to deliver innovative and effective strategies to protect global health.

Generated 12/20/23, 11:54 AM